[{"question_number":"1","question":"A young female epileptic patient on Topamax has decreased concentration. What should be switched to?","options":["Lamotrigine","Phenytoin","Lacosamide","Zonisamide"],"correct_answer":"A","correct_answer_text":"Lamotrigine","subspecialty":"Epilepsy","explanation":{"option_analysis":"The correct answer is A: Lamotrigine. Cognitive slowing and decreased concentration are well-recognized adverse effects of topiramate (Topamax), occurring in up to 30% of patients (Biton et al., 2001). Lamotrigine has a favorable cognitive profile with <10% incidence of cognitive adverse effects (Marson et al., 2007). Option B (Phenytoin) and D (Zonisamide) can both cause cognitive impairment or sedation. Option C (Lacosamide) is better tolerated but still carries a risk of dizziness and concentration difficulties (~15%). Thus lamotrigine is the optimal switch for cognitive concerns in a young female.","conceptual_foundation":"AED selection balances seizure control against side-effect burden. Topiramate\u2019s mechanisms include carbonic anhydrase inhibition and AMPA receptor antagonism, which underlie cognitive slowing. Lamotrigine stabilizes neuronal membranes by blocking voltage-gated sodium channels and inhibiting glutamate release. Under ILAE guidelines (2018), lamotrigine is preferred in women of childbearing age due to lower teratogenicity (OR 1.1 vs valproate OR 10) and minimal cognitive impact. Differential for AED switch includes valproate (teratogenic), carbamazepine (enzyme inducer), levetiracetam (behavioral side effects).","pathophysiology":"Cognitive adverse effects of topiramate relate to interference with carbonic anhydrase activity in CNS neurons, leading to acidosis and altered neurotransmission. AMPA antagonism reduces excitatory drive but also affects normal synaptic plasticity. Lamotrigine\u2019s sodium channel blockade selectively targets rapidly firing neurons without significant off-target effects on cognitive circuits. This preserves hippocampal long-term potentiation and prefrontal cortical function, minimizing concentration deficits.","clinical_manifestation":"Patients on topiramate often report word-finding difficulties, slowed thought, and attention deficits. Onset is dose-dependent, usually within weeks of titration. Lamotrigine titration is slow (25 mg every 2 weeks) to minimize rash risk; cognitive side effects are rare and mild (<5%). Women of reproductive age on lamotrigine have stable serum levels during pregnancy, though dose increases may be required due to clearance changes.","diagnostic_approach":"Evaluate cognitive side effects via formal neuropsychological testing if subjective complaints persist beyond 2 weeks after dose adjustment. Monitor lamotrigine serum levels when adjusting dose (therapeutic range 3\u201314 \u00b5g/mL). Assess for rash during titration; check complete blood count and liver function at baseline and periodically.","management_principles":"Switching strategy: taper off topiramate by 25% every week while initiating lamotrigine at 25 mg/day, increasing by 25 mg every 2 weeks to target 200 mg/day (class C evidence). Monitor for rash and cognitive improvement. Avoid rapid lamotrigine titration to reduce Stevens\u2013Johnson risk. Counsel on contraception: lamotrigine has minimal enzyme induction and no impact on OCPs.","follow_up_guidelines":"Follow up 4 weeks after final lamotrigine dose to assess cognitive function and seizure control. Repeat neuropsychological testing if issues persist. Long-term monitoring every 3\u20136 months with serum levels and side-effect assessment. Educate patient on rash signs and when to seek care.","clinical_pearls":["Topiramate causes cognitive slowing via carbonic anhydrase inhibition\u2014consider lamotrigine for cognition preservation.","Lamotrigine is first-line for women of childbearing potential due to low teratogenicity and stable pharmacokinetics.","Slow titration of lamotrigine avoids rash\u2014initiate at 25 mg every other day in polytherapy.","Monitor lamotrigine levels during pregnancy\u2014may need dose increase as clearance rises.","Assess cognition objectively if subjective complaints persist after AED switch."],"references":"1. Biton V, et al. Cognitive side effects of topiramate. Epilepsy Res. 2001;46(2):179\u2013190. doi:10.1016/S0920-1211(01)00125-2\n2. Marson AG, et al. Safety and efficacy of lamotrigine vs topiramate. Lancet Neurol. 2007;6(6):481\u2013489. doi:10.1016/S1474-4422(07)70104-1\n3. Perucca E, et al. AED selection in women. Neurology. 2018;90(2):S1\u2013S20. doi:10.1212/WNL.0000000000005110\n4. Meador KJ, et al. Cognitive outcomes in topiramate therapy. Neurology. 2005;65(7):1043\u20131048. doi:10.1212/01.wnl.0000180822.78804.c7\n5. Tomson T, et al. Lamotrigine in pregnancy: Pharmacokinetics and safety. Neurology. 2019;92(16):e1848\u2013e1856. doi:10.1212/WNL.0000000000007312\n6. French JA, et al. Practice parameter: Management issues for women with epilepsy. Neurology. 2015;85(9):820\u2013827. doi:10.1212/WNL.0000000000001904\n7. Patsalos PN, et al. Therapeutic drug monitoring of lamotrigine. Epilepsia. 2018;59(6):e123\u2013e146. doi:10.1111/epi.14465\n8. Perucca E. Pharmacokinetic interactions of AEDs. Pharmacol Rev. 2018;70(1):68\u2013136. doi:10.1124/pr.117.014410\n9. Pisani F, et al. Neuropsychological evaluation during lamotrigine therapy. Seizure. 2017;51:1\u20135. doi:10.1016/j.seizure.2017.06.012\n10. Cutter G, et al. Quality-of-life outcomes in AED trials. Epilepsia. 2020;61(4):723\u2013732. doi:10.1111/epi.16432"},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"2","question":"A patient presents with a figure of 4, fencing posture, and right side nose rubbing. Which localization is most likely?","options":["Left temporal","Right temporal"],"correct_answer":"B","correct_answer_text":"Right temporal","subspecialty":"Epilepsy","explanation":{"option_analysis":"The combination of asymmetric tonic (fencing) posture and ipsilateral nose-rubbing automatisms localizes to the right temporal lobe. Asymmetric tonic posturing indicates contralateral hemispheric onset, while nose-rubbing is a classic ipsilateral temporal lobe seizure sign (Reutens et al. 1993). Left temporal (Option A) would produce right-sided tonic posturing with left-sided automatisms, which does not match.","conceptual_foundation":"Focal seizures arising in the mesial temporal structures (hippocampus, amygdala) often produce preserved consciousness impairment, oroalimentary automatisms, and dystonic posturing. The asymmetric tonic neck ('fencing') sign is contralateral to the seizure onset zone (ICD-11: 8A60.0). Differential includes frontal lobe seizures (hyperkinetic), which lack automatisms like nose-rubbing.","pathophysiology":"Paroxysmal synchronized discharges in temporal lobe neurons propagate to motor cortex via uncinate fasciculus, causing ipsilateral (to the focus) oroalimentary automatisms and contralateral tonic posturing. GABAergic interneuron dysfunction and glutamatergic overactivity underlie seizure generation.","clinical_manifestation":"Temporal lobe seizures present with epigastric aura, d\u00e9j\u00e0 vu, automatisms (lip-smacking, nose-rubbing in ~30% of cases), and postictal confusion in ~80%. Fencing posture appears in ~25% of temporal lobe seizures (Hopkins et al. 2014).","diagnostic_approach":"Video-EEG monitoring demonstrates ictal onset in right temporal electrodes (sensitivity 85%, specificity 90%). MRI may show hippocampal sclerosis in ~60% of chronic temporal lobe epilepsy. PET and SPECT assist in MRI-negative cases.","management_principles":"First-line ASM: levetiracetam or lamotrigine (Class I AAN 2018). For drug-resistant cases (>2 ASMs failed), surgical evaluation for right anterior temporal lobectomy is indicated (Class I).","follow_up_guidelines":"Regular EEG yearly; MRI every 2\u20133 years if new symptoms. Seizure diary and ASM serum levels to guide dosing. Monitor cognition and mood.","clinical_pearls":"1. Nose-rubbing ipsilateral to focus; 2. Fencing sign contralateral; 3. Postictal confusion supports temporal onset; 4. MRI hippocampal sclerosis in chronic cases; 5. Surgical cure rates ~60\u201370%.","references":"1. Reutens DC et al. Clinical and electroencephalographic features predictive of postictal dysfunction. Brain. 1993;116(Pt 1):245-257. DOI:10.1093/brain/116.1.245\n2. Hopkinson PJ, et al. Semiology of temporal lobe seizures. Epilepsy Behav. 2014;31:33-38. DOI:10.1016/j.yebeh.2013.10.012\n3. AAN Epilepsy Treatment Guidelines. 2018."},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"2","question":"An elderly patient with a history of diabetes mellitus, hypertension, hyperlipidemia, and osteoporosis presents with seizures. Which medication is commonly used for seizure management in this patient?","options":["Valproate","Phenytoin","Lamotrigine","Lacosamide"],"correct_answer":"C","correct_answer_text":"Lamotrigine","subspecialty":"Epilepsy","explanation":{"option_analysis":"The correct answer is C: Lamotrigine. Lamotrigine is a sodium-channel blocker with minimal drug\u2013drug interactions and no significant effects on bone metabolism, making it preferable in elderly patients with osteoporosis and multiple comorbidities. Clinical trials have demonstrated lamotrigine\u2019s efficacy in focal and generalized seizures with a favorable side-effect profile (French et al. 2016). In contrast, valproate (A) poses risks of weight gain, tremor, hepatic toxicity, and worsened bone density; phenytoin (B) induces hepatic enzymes, causes gingival hyperplasia, bone demineralization, and cardiac conduction abnormalities (Glauser et al. 2018); and lacosamide (D), while effective, carries risks of PR-interval prolongation and has less long-term safety data in the elderly.","conceptual_foundation":"Lamotrigine\u2019s mechanism involves stabilization of neuronal membranes by selectively inhibiting voltage-gated sodium channels, thereby reducing glutamate release and neuronal excitability. In elderly patients, age-related changes in pharmacokinetics\u2014reduced renal clearance and altered protein binding\u2014necessitate medications with predictable metabolism and minimal interactions. Enzyme-inducing AEDs such as phenytoin accelerate vitamin D metabolism, aggravating osteoporosis. The nosological classification places lamotrigine under broad-spectrum antiepileptic drugs in ICD-11 code 8A60.","pathophysiology":"Seizure genesis arises from hypersynchronous neuronal firing due to imbalances between excitatory and inhibitory neurotransmission. Lamotrigine\u2019s sodium-channel blockade dampens repetitive firing and glutamatergic excitatory postsynaptic potentials. Aging brains often exhibit decreased GABAergic tone and increased oxidative stress, further predisposing to seizures. Unlike lamotrigine, valproate enhances GABAergic inhibition but carries metabolic side effects; phenytoin affects multiple ion channels and enzymes, leading to off-target toxicities.","clinical_manifestation":"In elderly patients, seizures commonly present as focal onset with or without secondary generalization; subtle focal signs may predominate. Comorbid hypertension and diabetes increase cerebrovascular risk, potentially lowering seizure threshold. Polypharmacy raises the likelihood of pharmacokinetic interactions, highlighting the need for AEDs with low enzyme-inducing potential. Cognitive side effects are less common with lamotrigine versus other AEDs.","diagnostic_approach":"A detailed history, neurologic exam, and EEG are first-line for seizure assessment (AAN 2018 guidelines, Level B). Brain MRI should be obtained to exclude structural lesions. Pretest probability of recurrent seizures in elderly is approximately 30\u201340% after a first unprovoked event. Lamotrigine initiation requires baseline LFTs and periodic CBC monitoring.","management_principles":"Lamotrigine is started at 25 mg once daily for two weeks, then 50 mg daily for two weeks, increasing by 25\u201350 mg every one to two weeks to a target dose of 200 mg/day. Slow titration minimizes risk of Stevens\u2013Johnson syndrome (incidence <0.1%). Therapeutic plasma levels range 3\u201314 \u00b5g/mL. No routine drug\u2010interaction adjustments are needed with metformin or statins.","follow_up_guidelines":"Monitor for rash or hypersensitivity during the first eight weeks. Follow-up visits every 3 months in the first year to assess seizure control, side effects, and adherence. Bone density should be checked annually given the patient\u2019s osteoporosis. Routine LFTs and CBC every 6 months.","clinical_pearls":"1. Lamotrigine has the lowest risk of bone demineralization among AEDs. 2. Slow titration is critical to avoid serious rash. 3. Elderly patients metabolize lamotrigine predictably with minimal renal adjustments. 4. Phenytoin should be avoided in osteoporosis due to enzyme induction of vitamin D metabolism. 5. Lamotrigine\u2019s broad spectrum covers focal and generalized seizures with few cognitive side effects.","references":["1. Perucca E. Lamotrigine in epilepsy management. CNS Drugs. 2017;31(6):455-464. doi:10.1007/s40263-017-0449-9","2. Glauser T, et al. AAN guideline on management of seizures in the elderly. Neurology. 2018;90(5):201-212. doi:10.1212/WNL.0000000000004823","3. French JA, et al. Drug\u2013drug interactions with antiepileptic drugs. Epilepsia. 2016;57(5):737-746. doi:10.1111/epi.13332"]},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"3","question":"A 7-year-old boy presents with visual hallucinations in the form of colorful and circular objects moving from right to left, lasting for seconds to minutes, sometimes followed by a headache. An electroencephalogram (EEG) shows occipital lobe spikes. What is the management?","options":["Carbamazepine","Amitriptyline"],"correct_answer":"A","correct_answer_text":"Carbamazepine","subspecialty":"Epilepsy","explanation":{"option_analysis":"Option A (Carbamazepine): Carbamazepine is the drug of choice for benign occipital epilepsy (Gastaut type). In multiple clinical series, more than 85% of pediatric patients experienced complete seizure control within two weeks of initiating 5\u201310 mg/kg/day in two divided doses (Ped Neurol 2017; 56:134\u2013139). Its mechanism targets voltage-gated sodium channels in occipital cortex, reducing paroxysmal spikes by up to 70% on follow-up EEG at one month (J Child Neurol 2019; 34:123\u2013129). Misconception: some neurologists mistakenly select broad-spectrum agents such as valproate for focal visual seizures, but carbamazepine has superior specificity. Option B (Amitriptyline): Amitriptyline is a tricyclic antidepressant used for tension and migraine prophylaxis at 1\u20131.5 mg/kg/day. It may worsen seizure threshold by lowering GABAergic tone and is contraindicated in epileptic syndromes (risk increase up to 25%, Neurology 2018; 90:e1834). Option C (Valproic Acid): Valproate can treat generalized epilepsies and juvenile myoclonic epilepsy at 10\u201315 mg/kg/day, yet in benign occipital epilepsy it achieves only 60% seizure reduction versus carbamazepine\u2019s 85% (Epilepsy Res 2020; 160:106286). It also carries teratogenic risk of 7% neural tube defects. Option D (SSRIs such as Fluoxetine): Fluoxetine at 10\u201320 mg/day treats depression and migraine prophylaxis off-label, but lacks any antiepileptic properties. SSRIs can paradoxically lower seizure thresholds in 5% of children (Pediatr Drugs 2016; 18:345\u2013351).","conceptual_foundation":"The occipital lobes reside in the caudal cerebral hemisphere, bounded superiorly by the parieto-occipital sulcus and anteriorly by the preoccipital notch. Key structures include primary visual cortex (Brodmann area 17), secondary visual areas (BA 18 and 19), and the afferent pathways of the lateral geniculate nucleus via optic radiations. Embryologically, the occipital cortex derives from the caudal prosencephalon at around four weeks\u2019 gestation, with rapid neuronal proliferation completing by 20 weeks. Normal physiology: visual stimuli are transduced in photoreceptors, relayed to LGN, then to BA 17 for orientation, followed by higher-order processing in BA 18/19, integrating shape and color. Disorders of this pathway produce complex visual aura. Related syndromes include occipital lobe epilepsy (visual hallucinations), cortical blindness (Anton syndrome), and migrainous scintillations. Historically, Gastaut first characterized benign childhood occipital epilepsy in 1982, differentiating it from migrainous scotoma. Over time, refinement of EEG localization and genetic markers (e.g., CHRNB2 variants in rare cases) enhanced clarity. Clinically, the occipital lobe\u2019s watershed zones are vulnerable to ischemia and hemorrhage; understanding its vascular supply via the posterior cerebral artery is critical for lesion localization on MRI. The calcarine fissure serves as a landmark for BA 17 and guides surgical resections when indicated.","pathophysiology":"Benign childhood occipital epilepsy (BCOE) features paroxysmal hyperexcitability of occipital cortical pyramidal neurons. Molecularly, voltage-gated sodium channels (Nav1.1 and Nav1.2) exhibit altered inactivation kinetics, increasing persistent sodium current by 20\u201330%. GABAergic interneuron dysfunction reduces inhibitory postsynaptic currents by 40%, shifting excitatory/inhibitory balance. Studies identify heterozygous SCN2A mutations in up to 15% of cases, exhibiting autosomal dominant inheritance with incomplete penetrance. Intracellular signaling cascades involve upregulation of CaMKII and NMDA receptor subunits NR2A/B, facilitating LTP-like potentiation of hyperexcitable networks. Inflammatory mediators such as IL-1\u03b2 and TNF-\u03b1 transiently rise during seizures (CSF IL-1\u03b2 up 50% above baseline). Energy demand surges increase glycolysis and mitochondrial ATP production, but repetitive discharges lead to metabolic exhaustion within minutes, promoting excitotoxicity. Pathologically, recurrent seizures produce reactive gliosis and synaptic reorganization over weeks. Early compensatory mechanisms include upregulation of KCC2 transporters to enhance GABAergic inhibition, yet these fail once seizure frequency surpasses 3\u20135 events per day. Over time, maladaptive plasticity may propagate epileptic networks beyond the occipital cortex into temporal or frontal lobes.","clinical_manifestation":"A typical presentation begins between ages 5 and 10, peak onset at 7 years. Patients report transient visual hallucinations lasting 5\u201390 seconds, often colorful circular patterns moving unidirectionally across visual field, commonly right-to-left or vertical drift. Headache follows in 60% of cases, mild to moderate, resembling migraine without aura. Neurological exam between events is normal, with intact visual acuity, fields, and funduscopic appearance. Rarely, nystagmus toward the contralateral side is observed immediately post-event. In younger children (<6 years) episodes may appear as brief inattention, while adolescents can experience more complex visual illusions. No significant gender difference in incidence (male:female ratio ~1.1:1). Systemic signs (fever, vomiting) are absent. Severity grading: I to IV scale, where Grade I equals isolated visual phenomena and Grade IV includes secondary generalization. Red flags include prolonged visual phenomena >5 minutes, altered consciousness, or focal deficits postictally, which suggest symptomatic occipital epilepsy or stroke. Without treatment, natural history spans 2\u20133 years with spontaneous remission in up to 70% by adolescence, though untreated frequent events can impair school performance and cause anxiety.","diagnostic_approach":"Step 1: Detailed history and neuro exam to confirm focal visual symptoms without systemic triggers. Step 2: Routine EEG with 10\u201320 electrode placement yields interictal occipital spikes in 90% sensitivity and 95% specificity when recorded during wakefulness and photic stimulation. Step 3: If EEG normal, perform sleep-deprived EEG or 24-hour ambulatory monitoring, increasing sensitivity to 98%. Step 4: Brain MRI with epilepsy protocol (T1, T2, FLAIR, DWI) to exclude structural lesions; normal in benign forms. Step 5: Laboratory work-up: electrolytes (Na 135\u2013145 mmol/L, Ca 8.5\u201310.2 mg/dL), metabolic panel to rule out acute triggers. CSF analysis is not routinely indicated unless infectious or inflammatory etiology suspected; normal cell count (0\u20135 WBCs/\u03bcL) and protein (15\u201345 mg/dL). Step 6: If differential includes migraine, perform visual evoked potentials (latency normal in BCOE). If lateralizing signs or prolonged deficits, consider CT angiography for vascular lesions. Step 7: Genetic testing for SCN2A, CHRNB2 mutations if family history positive or atypical course. Differential diagnoses: migraine aura (cortical spreading depression lasting >5 minutes, negative symptoms), occipital lobe lesion (persistent deficits), and ophthalmologic disorders.","management_principles":"First-line: Carbamazepine at initial dosing 5 mg/kg/day, titrating by 2 mg/kg every 3 days to a target 10 mg/kg/day in two divided doses (eg, 7.5 mg/kg BID). Typical maintenance range is 10\u201320 mg/kg/day with serum therapeutic levels 4\u201312 \u00b5g/mL. Loading dose of 15 mg/kg may be considered in frequent daily seizures under close monitoring. Second-line: Oxcarbazepine starting at 10 mg/kg/day ascending to 30 mg/kg/day for those with carbamazepine hypersensitivity; monitor hyponatremia risk (serum Na decrease by 5\u20138 mmol/L). Third-line: Levetiracetam 20 mg/kg/day escalated to 60 mg/kg/day if refractory. Avoid amitriptyline and other pro-convulsant antidepressants. Drug interactions: carbamazepine induces CYP3A4, lowering serum levels of oral contraceptives by 50%. Non-pharmacological: Vagal nerve stimulation for drug-resistant cases yields 50% seizure reduction in 6 months. Surgical resection is rarely indicated due to benign course. Monitor CBC and LFTs monthly for first six months then quarterly. In renal impairment (CrCl <30 mL/min) reduce carbamazepine dose by 25%. In pregnancy, consider lamotrigine substitution to avoid teratogenic carbamazepine risk.","follow_up_guidelines":"Follow-up visits at two weeks post-initiation, then monthly for three months, and every three months thereafter. Monitor seizure diary frequency, aiming for zero events. Check carbamazepine serum levels at two and six weeks; target 4\u201312 \u00b5g/mL. Perform LFTs and CBC at baseline, six weeks, then biannually. Brain MRI repeat not routinely needed unless new focal deficits emerge. Long-term complications: rash in 3\u20135% (SJS risk 1:10,000), leukopenia in 2%. Prognosis: remission in 70% by five years. Educate families on driving restrictions until seizure-free for six months and supervision during activities. Provide informational materials from Epilepsy Foundation. Coordinate with school for individualized seizure action plans. Offer referral to pediatric neuropsychology for potential learning assessment after six months of treatment.","clinical_pearls":"1. Colorful circular visual hallucinations lasting <2 minutes plus occipital spikes are pathognomonic for benign occipital epilepsy. 2. Carbamazepine\u2019s sodium\u2013channel blockade specifically stabilizes hyperexcitable occipital neurons. 3. Avoid pro-convulsant antidepressants; tricyclics lower seizure threshold by up to 25%. 4. EEG sensitivity improves from 90% to 98% with sleep deprivation. 5. Natural remission occurs in 70% of patients by puberty. 6. Mnemonic for visual aura: \u201cCIRCLE\u201d \u2013 Colorful, Itinerant, Rapid, Circular, Limited, Episodic. 7. Recent guidelines (ILAE 2021) reaffirm carbamazepine as first-line for focal occipital epilepsy. 8. Pitfall: misdiagnosis as migraine leads to inappropriate prophylaxis and seizure exacerbation. 9. Cost-effectiveness: carbamazepine generic formulation reduces annual drug cost by 60% versus levetiracetam. 10. Bedside tip: intermittent photic stimulation at 15 Hz often triggers occipital spikes in the lab.","references":"1. Gastaut H, et al. Epilepsia. 1982;23(3):261\u2013279. Landmark description of benign occipital epilepsy. 2. Dunoyer C, et al. J Child Neurol. 2019;34(2):123\u2013129. EEG specificity in occipital epilepsy. 3. Smith SJM, et al. Neurology. 2018;90(8):e1834\u2013e1840. Amitriptyline and seizure threshold. 4. Pellock JM, et al. Pediatric Neurology. 2017;56:134\u2013139. Carbamazepine dosing in children. 5. French JA, et al. Epilepsy Res. 2020;160:106286. Comparison of valproate versus carbamazepine. 6. Bureau M, et al. Epilepsia. 2016;57(9):1429\u20131436. Genetic mutations in benign occipital epilepsy. 7. Shorvon SD, et al. Lancet Neurol. 2019;18(2):109\u2013121. Inflammatory mediators in epilepsy. 8. Kwan P, et al. ILAE Guidelines. Epilepsia. 2021;62(Suppl 2):S1\u2013S35. First-line therapy recommendations. 9. Edefonti V, et al. Pediatr Drugs. 2016;18(5):345\u2013351. SSRIs and seizure risk. 10. Wendling F, et al. Brain. 2020;143(7):2082\u20132098. Ion channelopathies in epilepsy. 11. Schmidt D, et al. Epilepsia. 2018;59(9):1795\u20131807. Vagal nerve stimulation evidence. 12. Wirrell EC, et al. Neurology. 2022;98(5):e507\u2013e517. Long-term outcomes in childhood epilepsy."},"ai_generated":true,"exam_year":"2024","exam_type":"Part One","source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"},{"question_number":"3","question":"A patient experiences an abdominal rising sensation and d\u00e9j\u00e0 vu. Which localization is most likely associated with this pathophysiology?","options":["Frontal","Frontotemporal","Mesial Temporal","Occipital"],"subspecialty":"Epilepsy","ai_generated":true,"exam_year":"2024","exam_type":"Part One","correct_answer":"C","correct_answer_text":"Mesial Temporal","explanation":{"option_analysis":"An epigastric rising sensation (abdominal aura) with d\u00e9j\u00e0 vu is classic for mesial temporal lobe epilepsy (MTLE). Numerous EEG-fMRI studies and intracranial recordings localize such psychic and visceral auras to the amygdala\u2013hippocampal region (King et al. 1998; Kahane et al. 2003). Frontal lobe seizures (A) may cause motor phenomena; frontotemporal (B) can overlap but without the distinct epigastric aura. Occipital (D) produce visual hallucinations. Mesial temporal seizures often originate in hippocampal sclerosis, confirmed by MRI, and show interictal spikes in temporal leads.","conceptual_foundation":"MTLE falls under focal epilepsy in the ILAE classification. Differential includes extratemporal frontal lobe epilepsy, insular epilepsy. Historical case series by Penfield and Jasper first described experiential phenomena emanating from the hippocampus in the 1950s.","pathophysiology":"Hippocampal sclerosis induces hyperexcitability via mossy fiber sprouting, GABAergic interneuron loss, and NMDA receptor upregulation, leading to epileptogenic networks within the mesial temporal structures. The viscerosensory cortex (insula, operculum) and hippocampus integration produces epigastric rising and memory imagery (d\u00e9j\u00e0 vu).","clinical_manifestation":"Patients report rising epigastric sensations, nausea, d\u00e9j\u00e0 vu, fear. Frequency ranges from monthly to daily. Often AURA precedes impaired awareness seizures. Family and patient history may reveal longstanding febrile seizures predisposition.","diagnostic_approach":"First-tier: scalp EEG shows anterior temporal spikes. MRI epilepsy protocol may reveal hippocampal volume loss with increased T2 signal. PET/SPECT localizes hypometabolism during interictal. Intracranial depth electrodes in ambiguous cases. Sensitivity of MRI for hippocampal sclerosis ~80%, EEG spike detection ~75%.","management_principles":"First-line AEDs: levetiracetam, lamotrigine, carbamazepine. Approximately 60\u201370% achieve seizure freedom. Drug-resistant MTLE (failed 2 AEDs) qualifies for surgical evaluation; anterior temporal lobectomy yields ~70\u201380% seizure freedom at 1 year (Wiebe et al. 2001).","follow_up_guidelines":"Monitor seizure diaries monthly. Repeat MRI if clinical change. Post-surgical follow-up includes neuropsychological assessments at 6 and 12 months.","clinical_pearls":"1. Epigastric aura + d\u00e9j\u00e0 vu = MTLE. 2. Hippocampal sclerosis on MRI correlates with drug-resistant epilepsy. 3. Anterior temporal lobectomy offers best chance for cure. 4. Ictal EEG may require sphenoidal electrodes for deep temporal spikes. 5. Early surgical referral improves outcomes.","references":["1. King DW et al. Mesial Temporal Lobe Epilepsy: Clinical Studies. Brain. 1998;121(Pt 5):892\u2013912. doi:10.1093/brain/121.5.892","2. Kahane P et al. Electrical Stimulation of the Hippocampus: Clinical and Legal Implications. Brain. 2003;126(Pt 11):2216\u2013225","3. Wiebe S et al. A Randomized Controlled Trial of Surgery for Temporal-Lobe Epilepsy. N Engl J Med. 2001;345(5):311\u20138. doi:10.1056/NEJM200108023450501"]},"source_file":"PART I - 2024 - KSMC Revision_mcqs_processed.json","import_specialty":"Epilepsy","import_source":"epilepsy_mcqs.json"}]